This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center), Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2016.
Company Filing History:

Years Active: 2016
Title: Avital Artan: Innovator in Neuroprotective Natural Extracts
Introduction
Avital Artan is a prominent inventor based in Rehovot, Israel. She has made significant contributions to the field of neuroprotection through her innovative research and development of natural extracts. Her work focuses on the treatment and prevention of neural cell and neuro-pathological disorders.
Latest Patents
Avital Artan holds 1 patent for her invention titled "Neuroprotective natural extract from passion fruit." This patent outlines methods for treating and preventing neural cell and neuro-pathological disorders. The invention involves contacting neural cells or administering botanical raw material or an extract obtainable from passion fruits. Additionally, it includes compositions and a nutraceutical composition comprising the same.
Career Highlights
Throughout her career, Avital has worked with several esteemed organizations. She has been associated with the State of Israel's Ministry of Agriculture & Rural Development, the Agricultural Research Organization (Aro) at the Volcani Center, and Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Her work in these institutions has contributed to advancements in agricultural and neuroprotective research.
Collaborations
Avital has collaborated with notable colleagues, including Alon Samach and Oren Tirosh. These partnerships have enhanced her research efforts and expanded the impact of her innovations in the field.
Conclusion
Avital Artan's contributions to neuroprotection through her innovative patent and collaborative efforts highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in the treatment of neural disorders.